The London-listed firm had to pause global trials of its potential vaccine for COVID-19 after an unexplained illness in a participant, which sent its shares lower as the move was seen as dimming prospects for an early rollout.AstraZeneca did not immediately respond to a Reuters request for comment.
AstraZeneca coronavirus vaccine trials could resume next week – report
By REUTERS
05/07/2024 11:37 AM
By REUTERS
05/07/2024 11:35 AM
By REUTERS
05/07/2024 10:23 AM
By REUTERS
05/07/2024 10:21 AM
By REUTERS
05/07/2024 09:40 AM
By REUTERS
05/07/2024 08:09 AM
By REUTERS
05/07/2024 07:50 AM
By REUTERS
05/07/2024 06:50 AM
By MAARIV
05/07/2024 06:41 AM
By REUTERS
05/07/2024 06:37 AM
By WALLA!
05/07/2024 05:14 AM